List of Tables
Table 1. Long-acting Injectable Medications Market Trends
Table 2. Long-acting Injectable Medications Market Drivers & Opportunity
Table 3. Long-acting Injectable Medications Market Challenges
Table 4. Long-acting Injectable Medications Market Restraints
Table 5. Global Long-acting Injectable Medications Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Long-acting Injectable Medications Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Long-acting Injectable Medications Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Long-acting Injectable Medications Product Type
Table 9. Key Companies Time to Begin Mass Production of Long-acting Injectable Medications
Table 10. Global Long-acting Injectable Medications Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Injectable Medications as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Long-acting Injectable Medications Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Long-acting Injectable Medications Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Long-acting Injectable Medications Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Long-acting Injectable Medications Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Long-acting Injectable Medications Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Long-acting Injectable Medications Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Long-acting Injectable Medications Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Long-acting Injectable Medications Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Long-acting Injectable Medications Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Long-acting Injectable Medications Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Long-acting Injectable Medications Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Long-acting Injectable Medications Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Long-acting Injectable Medications Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Long-acting Injectable Medications Sales Value by Region (2019-2024) & (%)
Table 27. Global Long-acting Injectable Medications Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Long-acting Injectable Medications Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Long-acting Injectable Medications Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Long-acting Injectable Medications Sales Value, (2025-2030) & (US$ Million)
Table 31. Eli Lilly Basic Information List
Table 32. Eli Lilly Description and Business Overview
Table 33. Eli Lilly Long-acting Injectable Medications Products, Services and Solutions
Table 34. Revenue (US$ Million) in Long-acting Injectable Medications Business of Eli Lilly (2019-2024)
Table 35. Eli Lilly Recent Developments
Table 36. Alkermes Basic Information List
Table 37. Alkermes Description and Business Overview
Table 38. Alkermes Long-acting Injectable Medications Products, Services and Solutions
Table 39. Revenue (US$ Million) in Long-acting Injectable Medications Business of Alkermes (2019-2024)
Table 40. Alkermes Recent Developments
Table 41. Johnson & Johnson Basic Information List
Table 42. Johnson & Johnson Description and Business Overview
Table 43. Johnson & Johnson Long-acting Injectable Medications Products, Services and Solutions
Table 44. Revenue (US$ Million) in Long-acting Injectable Medications Business of Johnson & Johnson (2019-2024)
Table 45. Johnson & Johnson Recent Developments
Table 46. Zogenix Basic Information List
Table 47. Zogenix Description and Business Overview
Table 48. Zogenix Long-acting Injectable Medications Products, Services and Solutions
Table 49. Revenue (US$ Million) in Long-acting Injectable Medications Business of Zogenix (2019-2024)
Table 50. Zogenix Recent Developments
Table 51. DURECT Basic Information List
Table 52. DURECT Description and Business Overview
Table 53. DURECT Long-acting Injectable Medications Products, Services and Solutions
Table 54. Revenue (US$ Million) in Long-acting Injectable Medications Business of DURECT (2019-2024)
Table 55. DURECT Recent Developments
Table 56. Mapi Pharma Basic Information List
Table 57. Mapi Pharma Description and Business Overview
Table 58. Mapi Pharma Long-acting Injectable Medications Products, Services and Solutions
Table 59. Revenue (US$ Million) in Long-acting Injectable Medications Business of Mapi Pharma (2019-2024)
Table 60. Mapi Pharma Recent Developments
Table 61. GSK Basic Information List
Table 62. GSK Description and Business Overview
Table 63. GSK Long-acting Injectable Medications Products, Services and Solutions
Table 64. Revenue (US$ Million) in Long-acting Injectable Medications Business of GSK (2019-2024)
Table 65. GSK Recent Developments
Table 66. MedinCell Basic Information List
Table 67. MedinCell Description and Business Overview
Table 68. MedinCell Long-acting Injectable Medications Products, Services and Solutions
Table 69. Revenue (US$ Million) in Long-acting Injectable Medications Business of MedinCell (2019-2024)
Table 70. MedinCell Recent Developments
Table 71. Oakwood Labs Basic Information List
Table 72. Oakwood Labs Description and Business Overview
Table 73. Oakwood Labs Long-acting Injectable Medications Products, Services and Solutions
Table 74. Revenue (US$ Million) in Long-acting Injectable Medications Business of Oakwood Labs (2019-2024)
Table 75. Oakwood Labs Recent Developments
Table 76. Nanomi Basic Information List
Table 77. Nanomi Description and Business Overview
Table 78. Nanomi Long-acting Injectable Medications Products, Services and Solutions
Table 79. Revenue (US$ Million) in Long-acting Injectable Medications Business of Nanomi (2019-2024)
Table 80. Nanomi Recent Developments
Table 81. Pharmathen Basic Information List
Table 82. Pharmathen Description and Business Overview
Table 83. Pharmathen Long-acting Injectable Medications Products, Services and Solutions
Table 84. Revenue (US$ Million) in Long-acting Injectable Medications Business of Pharmathen (2019-2024)
Table 85. Pharmathen Recent Developments
Table 86. Kashiv BioSciences Basic Information List
Table 87. Kashiv BioSciences Description and Business Overview
Table 88. Kashiv BioSciences Long-acting Injectable Medications Products, Services and Solutions
Table 89. Revenue (US$ Million) in Long-acting Injectable Medications Business of Kashiv BioSciences (2019-2024)
Table 90. Kashiv BioSciences Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Long-acting Injectable Medications Downstream Customers
Table 94. Long-acting Injectable Medications Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Long-acting Injectable Medications Product Picture
Figure 2. Global Long-acting Injectable Medications Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Long-acting Injectable Medications Sales Value (2019-2030) & (US$ Million)
Figure 4. Long-acting Injectable Medications Report Years Considered
Figure 5. Global Long-acting Injectable Medications Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Long-acting Injectable Medications Revenue in 2023
Figure 7. Long-acting Injectable Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. First-generation Picture
Figure 9. Second-generation Picture
Figure 10. Global Long-acting Injectable Medications Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 11. Global Long-acting Injectable Medications Sales Value Market Share by Type, 2023 & 2030
Figure 12. Product Picture of Schizophrenia
Figure 13. Product Picture of Contraception
Figure 14. Product Picture of HIV
Figure 15. Product Picture of Others
Figure 16. Global Long-acting Injectable Medications Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Long-acting Injectable Medications Sales Value Market Share by Application, 2023 & 2030
Figure 18. North America Long-acting Injectable Medications Sales Value (2019-2030) & (US$ Million)
Figure 19. North America Long-acting Injectable Medications Sales Value by Country (%), 2023 VS 2030
Figure 20. Europe Long-acting Injectable Medications Sales Value (2019-2030) & (US$ Million)
Figure 21. Europe Long-acting Injectable Medications Sales Value by Country (%), 2023 VS 2030
Figure 22. Asia Pacific Long-acting Injectable Medications Sales Value (2019-2030) & (US$ Million)
Figure 23. Asia Pacific Long-acting Injectable Medications Sales Value by Country (%), 2023 VS 2030
Figure 24. South America Long-acting Injectable Medications Sales Value (2019-2030) & (US$ Million)
Figure 25. South America Long-acting Injectable Medications Sales Value by Country (%), 2023 VS 2030
Figure 26. Middle East & Africa Long-acting Injectable Medications Sales Value (2019-2030) & (US$ Million)
Figure 27. Middle East & Africa Long-acting Injectable Medications Sales Value by Country (%), 2023 VS 2030
Figure 28. Key Countries/Regions Long-acting Injectable Medications Sales Value (%), (2019-2030)
Figure 29. United States Long-acting Injectable Medications Sales Value, (2019-2030) & (US$ Million)
Figure 30. United States Long-acting Injectable Medications Sales Value by Type (%), 2023 VS 2030
Figure 31. United States Long-acting Injectable Medications Sales Value by Application (%), 2023 VS 2030
Figure 32. Europe Long-acting Injectable Medications Sales Value, (2019-2030) & (US$ Million)
Figure 33. Europe Long-acting Injectable Medications Sales Value by Type (%), 2023 VS 2030
Figure 34. Europe Long-acting Injectable Medications Sales Value by Application (%), 2023 VS 2030
Figure 35. China Long-acting Injectable Medications Sales Value, (2019-2030) & (US$ Million)
Figure 36. China Long-acting Injectable Medications Sales Value by Type (%), 2023 VS 2030
Figure 37. China Long-acting Injectable Medications Sales Value by Application (%), 2023 VS 2030
Figure 38. Japan Long-acting Injectable Medications Sales Value, (2019-2030) & (US$ Million)
Figure 39. Japan Long-acting Injectable Medications Sales Value by Type (%), 2023 VS 2030
Figure 40. Japan Long-acting Injectable Medications Sales Value by Application (%), 2023 VS 2030
Figure 41. South Korea Long-acting Injectable Medications Sales Value, (2019-2030) & (US$ Million)
Figure 42. South Korea Long-acting Injectable Medications Sales Value by Type (%), 2023 VS 2030
Figure 43. South Korea Long-acting Injectable Medications Sales Value by Application (%), 2023 VS 2030
Figure 44. Southeast Asia Long-acting Injectable Medications Sales Value, (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Long-acting Injectable Medications Sales Value by Type (%), 2023 VS 2030
Figure 46. Southeast Asia Long-acting Injectable Medications Sales Value by Application (%), 2023 VS 2030
Figure 47. India Long-acting Injectable Medications Sales Value, (2019-2030) & (US$ Million)
Figure 48. India Long-acting Injectable Medications Sales Value by Type (%), 2023 VS 2030
Figure 49. India Long-acting Injectable Medications Sales Value by Application (%), 2023 VS 2030
Figure 50. Long-acting Injectable Medications Industrial Chain
Figure 51. Long-acting Injectable Medications Manufacturing Cost Structure
Figure 52. Channels of Distribution (Direct Sales, and Distribution)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
